Safety of 300IR house dust mite sublingual tablet from pooled clinical trial and post-marketing data.

Margitta WormPascal DemolyYoshitaka OkamotoCarmen VidalKatia DaghildjianKwok YanThomas B CasaleKarl-Christian Bergmann

Published in: The World Allergy Organization journal (2024)

NCT00674700; Retrospectively registered 06 May 2008.NCT01199133; Retrospectively registered 09 September 2010.NCT01527188; Retrospectively registered 01 February 2012.NCT02443805; Registered 29 April 2015/EudraCT 2014-004223-46; Registered 16 September 2015.jRCT2080221872/JapicCTI-121917; Registered 01 August 2012.jRCT2080222929/JapicCTI-15298; Registered 04 August 2015.

Keyphrases

clinical trial
randomized controlled trial
machine learning
health risk